Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-03-18

Clinical Trial Update: Ashwagandha: Effects on Stress, Inflammation and Immune Cell Activation [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the effects of Ashwagandha on stress, inflammation, and immune cell activation; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ashwagandha (Withania somnifera)

Snippet

Sponsor: National University of Natural Medicine | Conditions: Inflammation, Cancer | Phase 1 | Status: COMPLETED